Zobrazeno 1 - 10 of 72 pro vyhledávání: '"IMPAACT P1026s protocol team"'
1
Pharmacokinetics of Tenofovir Alafenamide With Boosted Protease Inhibitors in Pregnant and Postpartum Women Living With HIV: Results From IMPAACT P1026s
Autor: Brooks, Kristina M, Pinilla, Mauricio, Stek, Alice M, Shapiro, David E, Barr, Emily, Febo, Irma L, Paul, Mary E, Deville, Jaime G, George, Kathleen, Knowles, Kevin, Rungruengthanakit, Kittipong, Browning, Renee, Chakhtoura, Nahida, Capparelli, Edmund V, Mirochnick, Mark, Best, Brookie M, IMPAACT P1026s Protocol Team
Publikováno v: Journal of acquired immune deficiency syndromes (1999), vol 90, iss 3
BackgroundTenofovir alafenamide (TAF) is a key component of HIV treatment, but pharmacokinetic data supporting the use of TAF during pregnancy are limited. In this study, we report pharmacokinetic, safety, and birth outcomes for TAF 25 mg with a boos
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______325::f55dc37f42cac4e3de8f262dc95f3ad0
https://escholarship.org/uc/item/61z7p39s
Zobrazit plný text záznamu
3
Pharmacokinetics of Increased Nelfinavir Plasma Concentrations in Women During Pregnancy and Postpartum
Autor: Eke, Ahizechukwu C, McCormack, Shelley A, Best, Brookie M, Stek, Alice M, Wang, Jiajia, Kreitchmann, Regis, Shapiro, David, Smith, Elizabeth, Mofenson, Lynne M, Capparelli, Edmund V, Mirochnick, Mark, IMPAACT P1026s Protocol Team
Publikováno v: Journal of clinical pharmacology, vol 59, iss 3
This study aims to evaluate the safety, acceptability, and pharmacokinetics (PK) of an increased dose of nelfinavir (NFV) during the third trimester of pregnancy. The study was registered as part of the International Maternal Pediatric Adolescent AID
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______325::ae964b43b60a61a377dbaac976f96c64
https://escholarship.org/uc/item/9t63t5x1
Zobrazit plný text záznamu
4
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
5
Alteration in cytochrome P450 3A4 activity as measured by a urine cortisol assay in HIV-1-infected pregnant women and relationship to antiretroviral pharmacokinetics
Autor: Aweeka, FT, Hu, C, Huang, L, Best, BM, Stek, A, Lizak, P, Burchett, SK, Read, JS, Watts, H, Mirochnick, M, Capparelli, EV, International Maternal Pediatric Adolescent AIDS Clinical Trials Group (IMPAACT) P1026s Protocol Team
Publikováno v: HIV medicine, vol 16, iss 3
ObjectivesPregnancy results in physiological changes altering the pharmacokinetics of drugs metabolized by cytochrome P450 3A4 (CYP3A4). The urinary ratio of 6-β hydroxycortisol to cortisol (6βHF : F) is a marker of CYP3A4 induction. We sought to e
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::550ffeb90d5f3078ad87d9577bb78c74
https://escholarship.org/uc/item/74z9p0fj
Zobrazit plný text záznamu
6
Interactions between etonogestrel-releasing contraceptive implant and 3 antiretroviral regimens
Autor: Regis Kreitchmann, Jiajia Wang, Nahida Chakhtoura, Alice Stek, Edmund V. Capparelli, Ahizechukwu C. Eke, David Shapiro, Mark Mirochnick, Brookie M. Best, Impaact P s Protocol Team
Publikováno v: Contraception. 105:67-74
ObjectivesLong-acting reversible contraceptives are effective contraceptives for women with HIV, but there are limited data on etonogestrel implant and antiretroviral therapy pharmacokinetic drug-drug interactions. We evaluated etonogestrel/antiretro
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d02a6e8b33a468a77bbd61948f4e4cb
https://doi.org/10.1016/j.contraception.2021.08.006
Zobrazit plný text záznamu
7
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
8
Pharmacokinetics of atazanavir boosted with cobicistat in pregnant and postpartum women with HIV
Autor: Renee Browning, Mark Mirochnick, Edmund V. Capparelli, Jeremiah D. Momper, Alice Stek, Kayla Denson, Kathleen M. Powis, David Shapiro, Impaact P s Protocol Team, Kathleen George, Nahida Chakhtoura, Mary E. Paul, Brookie M. Best, Martina L. Badell, Jiajia Wang, Kittipong Rungruengthanakit
Publikováno v: J Acquir Immune Defic Syndr
Journal of acquired immune deficiency syndromes (1999), vol 89, iss 3
BackgroundThis study evaluated atazanavir and cobicistat pharmacokinetics during pregnancy compared with postpartum and in infant washout samples.SettingA nonrandomized, open-label, parallel-group, multicenter prospective study of atazanavir and cobi
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a77c8548ce03cbd0814f31d103218aa
https://europepmc.org/articles/PMC8837686/
Zobrazit plný text záznamu
9
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
10
Pharmacokinetics of Darunavir and Cobicistat in Pregnant and Postpartum Women with HIV
Autor: Impaact P s Protocol Team, Mary E. Paul, Sandra K. Burchett, Jeremiah D. Momper, Nahida Chakhtoura, Edmund V. Capparelli, Derek Z Yang, Irma Febo, Kittipong Rungruengthanakit, Kathleen George, Kayla Denson, Alice Stek, Jiajia Wang, Gwendolyn B. Scott, Elizabeth Smith, David Shapiro, Mark Mirochnick, Brookie M. Best
Publikováno v: AIDS
AIDS (London, England), vol 35, iss 8
OBJECTIVE To evaluate darunavir and cobicistat pharmacokinetics during pregnancy compared with postpartum and in infant washout samples after delivery. DESIGN Nonrandomized, open-label, parallel-group, multicenter phase-IV prospective study of daruna
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a0375d8ab0ca15fbd7ad1843bb89d9a
https://europepmc.org/articles/PMC8173003/
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje